Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the detailed record of transactions filed by Gray Mary Ann. Insider active across 5 companies, notably Sarepta Therapeutics, Inc.. Aggregated, 18 filings have been logged. Activity tracked since 10 December 2021. The latest transaction was disclosed on 30 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Gray Mary Ann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
4,956 sharesCommon StockSEC:0001261974-26-000003:0
4,956 shares0Common StockSEC:0001261974-26-000002:0
23,500 shares0Common StockSEC:0000950170-25-088062:0
5,250 shares0Common StockSEC:0001415889-25-015974:0
16,500 shares0Common StockSEC:0000950170-24-073683:0
5,995 shares0Common StockSEC:0001209191-24-000601:0
8,676 shares0Common StockSEC:0001209191-23-051691:0
4,916 shares0Common StockSEC:0001209191-23-041218:0
5,503 shares0Common StockSEC:0001209191-23-029631:0
2,953 shares0Common StockSEC:0001209191-22-017352:0
967 shares0Common StockSEC:0001209191-21-069638:0
232,440 sharesCommon StockSEC:0000908662-16-000433:0
6,000 sharesCommon StockSEC:0000908662-16-000402:0
75,000 sharesCommon StockSEC:0000908662-16-000402:1
75,000 sharesCommon StockSEC:0000908662-16-000402:2
8,107 sharesCommon StockSEC:0000908662-16-000402:3
25,000 sharesCommon StockSEC:0000908662-16-000402:4
33,333 sharesCommon StockSEC:0000908662-16-000402:5
About Gray Mary Ann
GRAY MARY ANN is a declarant associated with DYAX CORP, BioAtla, Inc., RAPT Therapeutics, Inc., Sarepta Therapeutics, Inc. and Keros Therapeutics, Inc. She is listed as Director at BioAtla, Inc., RAPT Therapeutics, Inc., Sarepta Therapeutics, Inc. and Keros Therapeutics, Inc. The record shows 18 filings, with recent filings dated from 2016-01-19 to 2026-03-05, and the stated transaction nature is Attribution.